Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
Cancer and Metastasis Reviews · 2024-03 · 43 (1) · 197-228
DOI: 10.1007/s10555-024-10172-z ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer and Metastasis Reviews, online erschienen am 08.02.2024. Verfasst von Gh Rasool Bhat und 16 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Centre for Human Genetics, Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India. Hauptthemen laut MEDLINE: Cell Plasticity, Neoplasms. Die Arbeit wurde bisher 308-mal zitiert (Crossref) und nennt 249 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sidra Medicine, Sidra Medical and Research Center.
Abstract (Originalsprache)
Cancer is a complex disease displaying a variety of cell states and phenotypes. This diversity, known as cancer cell plasticity, confers cancer cells the ability to change in response to their environment, leading to increased tumor diversity and drug resistance. This review explores the intricate landscape of cancer cell plasticity, offering a deep dive into the cellular, molecular, and genetic mechanisms that underlie this phenomenon. Cancer cell plasticity is intertwined with processes such as epithelial-mesenchymal transition and the acquisition of stem cell–like features. These processes are pivotal in the development and progression of tumors, contributing to the multifaceted nature of cancer and the challenges associated with its treatment. Despite significant advancements in targeted therapies, cancer cell adaptability and subsequent therapy-induced resistance remain persistent obstacles in achieving consistent, successful cancer treatment outcomes. Our review delves into the array of mechanisms cancer cells exploit to maintain plasticity, including epigenetic modifications, alterations in signaling pathways, and environmental interactions. We discuss strategies to counteract cancer cell plasticity, such as targeting specific cellular pathways and employing combination therapies. These strategies promise to enhance the efficacy of cancer treatments and mitigate therapy resistance. In conclusion, this review offers a holistic, detailed exploration of cancer cell plasticity, aiming to bolster the understanding and approach toward tackling the challenges posed by tumor heterogeneity and drug resistance. As articulated in this review, the delineation of cellular, molecular, and genetic mechanisms underlying tumor heterogeneity and drug resistance seeks to contribute substantially to the progress in cancer therapeutics and the advancement of precision medicine, ultimately enhancing the prospects for effective cancer treatment and patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Advanced Centre for Human Genetics, Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India.
- Institute of Human Genetics, University of Jammu, Jammu, Jammu and Kashmir, India.
- Department of Human Genetics-Precision Medicine in Diabetes, Obesity and Cancer Program, Sidra Medicine, Doha, Qatar.
- Iron Biology Group, Research Institute of Medical and Health Science, University of Sharjah, Sharjah, UAE.
- Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Prince Fahad Bin Sultan Chair for Biomedical Research, University of Tabuk, Tabuk, Saudi Arabia.
- Department of Surgical Oncology, Faculty of Medicine, University of Tabuk, Tabuk, Saudi Arabia.
Förderung
- Sidra Medicine
- Sidra Medical and Research Center
Zitieren
APA
Bhat, G. R., Sethi, I., Sadida, H. Q., Rah, B., Mir, R., Algehainy, N., Albalawi, I. A., Masoodi, T., Subbaraj, G. K., Jamal, F., Singh, M., Kumar, R., Macha, M. A., Uddin, S., Akil, A. S. A., Haris, M., & Bhat, A. A. (2024). Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance. Cancer and Metastasis Reviews, 43(1), 197-228. https://doi.org/10.1007/s10555-024-10172-z
Vancouver
Bhat GR, Sethi I, Sadida HQ, Rah B, Mir R, Algehainy N, et al. Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance. Cancer and Metastasis Reviews. 2024;43(1):197-228. doi:10.1007/s10555-024-10172-z
BibTeX
@article{Bhat2024,
author = {Bhat, Gh Rasool and Sethi, Itty and Sadida, Hana Q and Rah, Bilal and Mir, Rashid and Algehainy, Naseh and Albalawi, Ibrahim Altedlawi and Masoodi, Tariq and Subbaraj, Gowtham Kumar and Jamal, Farrukh and Singh, Mayank and Kumar, Rakesh and Macha, Muzafar A and Uddin, Shahab and Akil, Ammira S Al-Shabeeb and Haris, Mohammad and Bhat, Ajaz A},
title = {Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance},
journal = {Cancer and Metastasis Reviews},
year = {2024},
volume = {43},
number = {1},
pages = {197--228},
doi = {10.1007/s10555-024-10172-z}
}
EUVIMED